Observational ambispective multicentre study to describe and assess the evolution of disease burden in severe asthma patients, overall and split by presence of T2 inflammation. The BREATHE Study.
Datos básicos
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
ASTRAZENECA FARMACÉUTICA SPAIN, S.A.
Portal de investigación